jurnalul român de psihofarmacologie romanian journal of ...

157. Huttunen MO, Piepponen T, Rantanen H, Larmo I, Nyholm R, Raitasuo R. Risperidone
versus zuclopenthixol in the treatment of acute schizophrenic episodes: a double-blind
parallel group trial. Acta Psychiatr Scand 1995; 271-277.
158. Conley RR, Mahmoud R. A randomized double-blind study of risperidone and olanzapine
in the treatment of schizophrenia or schizoaffective disorder. Am J Psychiatry 2001;
158:765-774.
159. Peuskens, J. Amisulpride versus risperidone in chronic schizophrenia: results of a 6-
months, double-blind study assessing efficacy and tolerability. Eur Neuropsychopharmacol
2001; 11(suppl):294.
160. Tollefson GD, Andersen SW, Tran PV. The course of depressive symptoms in predicting
relapse in schizophrenia: a double-blind, randomized comparison of olanzapine and
risperidone. Biol Psychiatry 1999; 46:365-373.
161. Glick ID, Lemmens P, Vester-Biokland E. Treatment of the symptoms of schizophrenia: a
combined analysis of double-blind studies comparing risperidone with haloperidol and
other antipsychotic agents. Int Clin Psychopharmacol 2001; 16:265-274.
162. McGurk SR, Green MF, Wirshing WC, Ames D, Marshall BD Jr, Marder SR, Mintz J. The
effects of risperidone vs. haloperidol on cognitive functioning in treatment-resistant
schizophrenia: the trail making test. CNS Spectrum 1997; 2:60-64.
163. Green MF, Marshall BD Jr, Wirshing WC, Ames D, Marder SR, McGurk S, Kern RS,
Mintz J. Does risperidone improve verbal working memory in treatment-resistant
schizophrenia? Am J Psychiatry 1997; 154:799-804.
164. Kee KS, Kern RS, Marshall BD Jr, Green MF. Risperidone versus haloperidol for
perception of emotion in treatment-resistant schizophrenia: preliminary findings.
Schizophrenia Res 1998; 31:159-165.
165. Kern RS, Green MF, Marshall BD Jr, Wirshing WC, Wirshing D, McGurk SR, Marder SR,
Mintz J. Risperidone versus haloperidol on secondary memory: can newer medications aid
learning? Schizophr Bull 1999; 25:223-232.
166. Liu SK, Chen WJ, Chang CJ, Lin HN. Effects of atypical neuroleptics on sustained
attention deficit in schizophrenia: a trial of risperidone and haloperidol.
Neuropsychopharmacology 2000; 22:311-319.
167. Purdon SE, Jones BD, Stip E, Labelle A, Addington D, David SR, Breier A, Tollefson GD.
Neuropsychological change in early faze schizophrenia during 12-months of treatment with
olanzapine, risperidone or haloperidol. The Canadian Collaborative Group for research in
schizophrenia. Arch Gen Psychiatry 2000; 57:249-258.
145